D32.0
Conditions
Interventions
Group 1: Children (=10 years of age), adolescents, and adults who developed meningioma in childhood and adolescence and received therapy and participated in the HIT-ENDO, KRANIOPHARYNGEOM 2000/2007, o
Sponsors
Klinikum Oldenburg AöR, Universitätsklinik für Kinder- und Jugendmedizin, Allgemeine Kinderheilkunde, Hämatologie und Onkologie, Studienzentrale Kraniopharyngeom
Eligibility
Sex/Gender
All
Age
10 Years to No maximum
Inclusion criteria
Inclusion criteria: - Existing participation in the HIT-ENDO, KRANIOPHARYNGEOM 2000/2007, or KRANIOPHARYNGEOM Registry 2019 (26) studies - Diagnosis of meningioma before the age of 18 years - Histological or image morphological confirmation of the meningioma - Completed therapy for the meningioma or no therapy
Exclusion criteria
Exclusion criteria: - Current age < 10 years - Patients under current oncological therapy for meningioma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health-related quality of life from the study population compared with a normative reference population. | — |
Secondary
| Measure | Time frame |
|---|---|
| Influences of different therapies, etiologies, histologies, WHO grades, tumor localizations, as well as time distance to diagnosis on health-related quality of life are investigated. In addition, the health-related quality of life of meningioma patients will be compared with craniopharyngeal patients. | — |
Countries
Germany
Contacts
Public ContactHermann Müller
Klinikum Oldenburg AöR, Universitätsklinik für Kinder- und Jugendmedizin, Allgemeine Kinderheilkunde, Hämatologie und Onkologie, Studienzentrale Kraniopharyngeom
Outcome results
None listed